News

Each year, approximately 177,000 adults aged 65 and older are hospitalized in the United States due to RSV, and an estimated ...
A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...
The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory ...
A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...
ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new ...
which causes approximately 158,000 adult hospital admissions annually from RSV disease, a common respiratory virus with symptoms that can be severe or even life-threatening," said Alexandre de ...
The U.S. Centers for Disease Control and Prevention's vaccine experts are expected to vote on expanding access to respiratory ...
When adults and older children catch RSV, they usually have milder symptoms that are similar to those of a cold. But RSV can be serious for some, including: People over 65 Those with a weakened ...